Found 8 matching trials
uPAR PET/CT for Staging Advanced and Localised Oral and Oropharyngeal Cancer PHASE2 uPAR PET/CT for Staging Advanced and Localised oral and oropharyngeal cance...
Show More Location
Department of Clinical Physiology, Nuclear Medicine and PET, Rigshospitalet
Learn More & Join Trial
PET/CT Imaging of uPAR-expression in Patients With Neuroendocrine Tumors Using 68Ga-NOTA-AE105 PHASE2 The aim of this non-randomised, prospective study is to investigate the app...
Show More Location
Department of Clinical Physiology, Nuclear Medicine and PET, Rigshospitalet
Learn More & Join Trial
Evaluation of a New Radiotracer (68Ga-NOTA-AE105) for Diagnosing Aggressive Cancer With Positron Emission Tomography PHASE1 The primary objective of the study is to test a new radiotracer called 68Ga...
Show More Location
Department of Clinical Physiology, Nuclear Medicine and PET, Rigshospitalet
Learn More & Join Trial
uPAR-PET for Prognostication in Patients With Non-small Cell Lung Cancer, Malignant Pleural Mesothelioma and Large Cell Neuroendocrine Carcinoma of the Lung PHASE2 uPAR PET/CT as a prognostic marker in non-small cell lung cancer....
Location
Department of Clinical Physiology, Nuclear Medicine and PET, Rigshospitalet
Learn More & Join Trial
uPAR PET/CT and FDG PET/MRI for Preoperative Staging of Bladder Cancer PHASE2 The sensitivity and specificity of uPAR PET/CT with the radioligand 68GaNOT...
Show More Location
Department of Clinical Physiology, Nuclear Medicine and PET, Rigshospitalet
Learn More & Join Trial
uPAR PET/CT for Preoperative Staging of Breast Cancer Patients PHASE2 The sensitivity and specificity of uPAR PET/CT for preoperative detection o...
Show More Location
Department of Clinical Physiology, Nuclear Medicine and PET, Rigshospitalet
Learn More & Join Trial
uPAR PET/CT in Radium-223-dichloride Treatment of Patients With Metastatic Castration-resistant Prostate Cancer PHASE2 The purpose of this study is to investigate the applicability of urokinase ...
Show More Learn More & Join Trial
uPAR-PET/MRI in Glioblastoma Multiforme PHASE2 The purpose of this study is to investigate the applicability of urokinase ...
Show More Location
Department of Clinical Physiology, Nuclear Medicine and PET, Rigshospitalet
Learn More & Join Trial